Runt-Related Transcription Factor 1 (RUNX1) Kits ELISA

Core binding factor (CBF) is a heterodimeric transcription factor that binds to the core element of many enhancers and promoters. De plus, nous expédions RUNX1 Anticorps (338) et RUNX1 Protéines (9) et beaucoup plus de produits pour cette protéine.

list all ELISA KIts Gène GeneID UniProt
RUNX1 12394 Q03347
RUNX1 861 Q01196
RUNX1 50662 Q63046
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne

Top RUNX1 Kits ELISA sur

Showing 5 out of 11 products:

Catalogue No. Reactivité Sensibilité Gamme Images Quantité Livraison Prix Détails
Rat 6.25 pg/mL 25-1600 pg/mL Typical standard curve 96 Tests 15 to 18 Days
  2 x 96 Tests 2 to 3 Days
  96 Tests 1 to 2 Days
  96 Tests 2 to 3 Days
  96 Tests 2 to 3 Days

Plus Kits ELISA pour RUNX1 partenaires d'interaction

Mouse (Murine) Runt-Related Transcription Factor 1 (RUNX1) interaction partners

  1. Embryos lacking the KH domain poly(C) binding protein, Pcbp2, are selectively deficient in the definitive erythroid lineage. Compared to wild-type controls, transcript splicing analysis of the Pcbp2(-/-) embryonic liver reveals accentuated exclusion of an exon (exon 6) that encodes a highly conserved transcriptional control segment of the hematopoietic master regulator, Runx1.

  2. that RUNX1/ETO maintains leukemia by promoting cell cycle progression and identifies G1 CCND-CDK complexes as promising therapeutic targets for treatment of RUNX1/ETO-driven acute myeloid leukemia

  3. RUNX1 is found only in the relatively rare wave 2 and 3 progenitors in the embryo.RUNX1 loss blocked the formation of wave 2 and 3 progenitors from this rare population of "hemogenic" endothelial cells (HE). RUNX1 was required for blood cell formation from HE. Review.

  4. RUNX1 may be involved in the transition of the myometrium from a quiescent into a contractile state in preparation for labor.

  5. B7-H4 enhances the differentiation of murine leukemia-initiating cells via the PTEN/AKT/RCOR2/RUNX1 pathways.

  6. Reducing Runx1 function drives increased contractility after myocardial infarction, thereby preserving LV systolic function and preventing adverse cardiac remodeling.

  7. Runx/Cbfb complexes protect group 2 innate lymphoid cells from exhausted-like hyporesponsiveness during allergic airway inflammation.

  8. Deletion of Runx1 in mouse T-ALL impairs cell growth. RUNX1 depletion consistently resulted in reduced cell proliferation and increased apoptosis.

  9. Ezh2 and Runx1 mutations collaborate to initiate lympho-myeloid leukemia in early thymic progenitors

  10. RUNX1 promoted TGF-beta-induced partial EMT by increasing transcription of the PI3K subunit p110delta, which mediated Akt activation.

  11. The promoter regions of Runx1 is targets of STAT4 and that STAT4 binding during NK cell activation induces epigenetic modifications of Runx1 gene loci resulting in increased expression.

  12. Results suggest that AML1/ETO expression determines a more mobile and less adherent phenotype in preleukemic cells, therefore altering the interaction with the hematopoietic niche, potentially leading to the migration across the bone marrow barrier and to disease progression

  13. Gene expression profiling of HEPs revealed a RUNX1c-induced proinflammatory molecular signature, supporting previous studies demonstrating proinflammatory signaling as a regulator of HSC emergence.

  14. Histones showed limited activation in regions of single TF binding, while enhancers that bind NF-E2 and either RUNX1, FLI1 or both TFs gave the highest signals for TF occupancy and H3K4me2; these enhancers associated best with genes activated late in MK maturation.

  15. the ability of Runx1 to induce endothelial-to-hematopoietic transition (EHT) in non-hemogenic endothelial cells depends on the anatomical location of the cell and the developmental age of the conceptus

  16. CDK6 kinase activity negatively regulates the conversion of fat-storing cells into fat-burning cells by suppressing RUNX1, and may be a therapeutic target for the treatment of obesity and related metabolic diseases

  17. RUNX1 dosage plays a pivotal role in hemogenic endothelium maturation and the establishment of the hematopoietic system.

  18. These results suggest that RUNX1 may be an essential modulator in BMP9- induced osteogenic differentiation of mesenchymal stem cells.

  19. Loss of Runx1 and Runx2 inhibits prostate cell motility.

  20. In vivo, in vitro and systems biology results show that Runx1 exerts a pro-neurogenic function in neural precursor cells in vitro, while in vivo data remained inconclusive.

Human Runt-Related Transcription Factor 1 (RUNX1) interaction partners

  1. Results find reduced RUNX1 expression to be associated with decreased survival probability in patients with breast cancer (BC). Its ectopic expression inhibits stemness properties of BC cell lines through repressing the expression of ZEB1 providing evidence that RUNX1 has antitumor activity in breast cancer cells.

  2. Aberrant CD79a and/or PAX5 expression can be found in Acute Myelogenous Leukemia cases with RUNX1 mutations even without the translocation t(8; 21).

  3. Our work demonstrates for the first time the predominant co-repressive function of SKI in acute myeloid leukemia cells on a genome-wide scale and uncovers the transcription factor RUNX1 as an important mediator of SKI-dependent transcriptional repression.

  4. our present study strongly suggests that an autonomous RUNX1-p53-CBFB regulatory triangle plays a vital role in the maintenance and the acquisition of chemo-resistance of AML cells, and potentially provides novel therapeutic targets for anti-leukemia strategy.

  5. RUNX1 regulates the oncogene KIT, by binding to its enhancer, and through interaction with FUBP1.

  6. this study suggests that RUNX1 mutations might be a poor prognostic factor in the risk classification for pediatric acute myeloid leukemia.

  7. that RUNX1/ETO maintains leukemia by promoting cell cycle progression and identifies G1 CCND-CDK complexes as promising therapeutic targets for treatment of RUNX1/ETO-driven acute myeloid leukemia

  8. Study found that CBFB binds to and enhances the translation of RUNX1 mRNA, which encodes the binding partner of CBFB. CBFB binds and regulates the translation of hundreds of mRNAs through hnRNPK and facilitate translation initiation by eIF4B. Data propose that breast cancer cells evade translation and transcription surveillance simultaneously through downregulating CBFB.

  9. Minimal residual disease (MRD) monitoring and mutational landscape in AML with RUNX1-RUNX1T1.

  10. Data show that miR-20a attenuated the killing effect of NK cells to cervical cancer cells by directly targeting runt-related transcription factor 1 (RUNX1).

  11. Serum NEF is a sensitive diagnostic and prognostic marker for gastric carcinoma. NEF siRNA silencing promoted, and overexpression inhibited, gastric carcinoma proliferation. In addition, NEF overexpression promoted, and NEF siRNA silencing inhibited, Runx1 expression. Therefore, it was concluded that lncRNA NEF may participate in the regulation of cancer cell proliferation by regulating Runx1 expression

  12. identified RNF38 as a novel E3 ligase that modifies RUNX1 function without inducing its degradation

  13. These data indicate that RUNX1 regulates A4GALT and thereby the expression of clinically important glycosphingolipids implicated in blood group incompatibility and host-pathogen interactions.

  14. The human RUNX1 gene was cloned as one of a pair of genes disrupted by the (8;21)(q22;q22) translocation in acute myeloid leukemia. The human RUNX1 protein binds the "core-binding" DNA motif. The inv(16)(p13.1;q22) mutation associated with AML created a chimeric protein that fused the non-DNA-binding CBFbeta subunit to the coiled-coil tail region of a smooth muscle myosin heavy chain. Review.

  15. RUNX1 may be involved in the transition of the myometrium from a quiescent into a contractile state in preparation for labor.

  16. High frequency of RUNX1 mutation in myelodysplastic syndrome patients with whole-arm translocation of der(1;7)(q10;p10).

  17. ZFP36L2 could be transactivated by AML1, which subsequently induced cell-cycle arrest and apoptosis of leukemia cells

  18. Study reports differential regulation of gene expression by RUNX1-RUNX1T1 oncoprotein and MAPK1 as determined by genome-wide expression analysis responsible for the phenotypic features of acute myeloid leukaemia with karyotypic discernible translocation (t)(8;21)(q22;q22).

  19. identified most of these factors as RUNX1-RUNX1T1 targets, with Ras Homolog Family Member (RHOB) overexpression being the core of this network

Zebrafish Runt-Related Transcription Factor 1 (RUNX1) interaction partners

  1. Our data suggest that runx1 and cbfb are required at 2 different steps during early hematopoietic stem cell development

  2. We propose that cohesin and CTCF have distinct functions in the regulation of runx1 during zebrafish embryogenesis.

  3. Morpholino knockdown of Myef2 or Runx1 in zebrafish results in reduced numbers of hematopoietic stem cells, suggesting that these two factors also interact in vivo to regulate hematopoiesis.

  4. Runx1 is induced by high Pu.1 level and in turn transrepresses pu.1 expression, thus constituting a negative feedback loop that fashions a favorable Pu.1 level required for balanced fate commitment to neutrophils versus macrophages.

  5. hematopoietic stem cell numbers depended on activity of the transcription factor Runx1, on blood flow, and on proper development of the dorsal aorta

  6. in zebrafish adult HSCs can be formed without an intact runx1.

  7. isolation and characterization by spatiotemporal expression detected in the developing zebrafish

  8. Zebrafish embryos lacking Rad21, or cohesin subunit Smc3, fail to express runx3 and lose hematopoietic runx1 expression in early embryonic development.

Xenopus laevis Runt-Related Transcription Factor 1 (RUNX1) interaction partners

  1. Xaml1/Runx1 is required for the specification of Rohon-Beard sensory neurons in Xenopus.

  2. ETV6-RUNX1 (TEL-AML1) fusion and hyperdiploidy (>50 chromosomes) are favorable genetic features in childhood acute lymphoblastic leukemia (ALL).

  3. reveal a shift in Runx2 function protein during vertebrate evolution towards its exclusive roles in cartilage hypertrophy and bone differentiation within the amniote lineage

RUNX1 profil antigène

Antigen Summary

Core binding factor (CBF) is a heterodimeric transcription factor that binds to the core element of many enhancers and promoters. The protein encoded by this gene represents the alpha subunit of CBF and is thought to be involved in the development of normal hematopoiesis. Chromosomal translocations involving this gene are well-documented and have been associated with several types of leukemia. Three transcript variants encoding different isoforms have been found for this gene.

Gene names and symbols associated with RUNX1

  • uncharacterized LOC473981 (LOC473981) anticorps
  • runt-related transcription factor (runt) anticorps
  • runt related transcription factor 1 (Runx1) anticorps
  • runt related transcription factor 1 (RUNX1) anticorps
  • runt-related transcription factor 1 (runx1) anticorps
  • runt related transcription factor 1 L homeolog (runx1.L) anticorps
  • runt-related transcription factor 1 (RUNX1) anticorps
  • runt-related transcription factor 1 (Runx1) anticorps
  • AI462102 anticorps
  • aml anticorps
  • aml-1 anticorps
  • Aml1 anticorps
  • aml1-evi-1 anticorps
  • amlcr1 anticorps
  • cbfa2 anticorps
  • evi-1 anticorps
  • Pebp2a2 anticorps
  • pebp2ab anticorps
  • Pebpa2b anticorps
  • Runx-1 anticorps
  • runx1 anticorps
  • runxa anticorps
  • XAML anticorps
  • Xaml1 anticorps

Protein level used designations for RUNX1

runt-related transcription factor 1 , runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene) , runt-related transcription factor , runt protein , CBF-alpha-2 , PEA2-alpha B , PEBP2-alpha B , SL3-3 enhancer factor 1 alpha B subunit , SL3/AKV core-binding factor alpha B subunit , acute myeloid leukemia 1 protein , core binding factor alpha 2 , core-binding factor subunit alpha-2 , oncogene AML-1 , polyomavirus enhancer-binding protein 2 alpha B subunit , runt domain, alpha subunit 2 , AML1-EVI-1 fusion protein , core-binding factor, runt domain, alpha subunit 2 , aml1 , runt-related transcription factor a , runx1a , Acute myeloid leukemia 1 protein , Core-binding factor subunit alpha-2 , aml1 oncogene , ch-runtB2 , acute myeloid leukemia 1 , factor, runt domain, alpha subunit 2 , core-binding factor runt domain alpha subunit 2 (acute myeloid leukemia 1 oncogene) , runt related transcription factor 1

473981 Pan troglodytes
100302713 Saccoglossus kowalevskii
12394 Mus musculus
861 Homo sapiens
58126 Danio rerio
379657 Xenopus laevis
396152 Gallus gallus
487746 Canis lupus familiaris
529631 Bos taurus
50662 Rattus norvegicus
100512633 Sus scrofa
100724149 Cavia porcellus
Fournisseurs de qualité sélectionnés pour RUNX1 (RUNX1) Kits ELISA
Avez-vous cherché autre chose?